Clinical Trials Directory

Trials / Terminated

TerminatedNCT03318640

Mindfulness and Cognition in Schizophrenia

Effect of Mindfulness (MBSR) on the Parasympathetic System and Cognition in Schizophrenia

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Mindfulness (innovative and integrative practice in care) allows the individual to adapt his/her behavior (physical and emotional), in a stressful environment, by regulating cardiac activity, especially the parasympathetic system. In schizophrenia, despite the positive effect of treatments on symptoms (delusions and hallucinations), patients have altered markers of the parasympathetic (high frequency, HF) system. The investigator propose a session of Mindfulness Based Stress Reduction (MBSR) for patients suffering from schizophrenia in order to measure the impact on the parasympathetic system (HF), self-awareness (being well in one's body and being aware of their own actions; EASE) and cognition (attention) in relation to the management of conflicts or emotions. The study compare with patients who receive a session of techniques based on the management of emotions and social cognition (cinemotion, Michael's Game and Tom Remed).

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulnessPatient will have 8 sessions (1h30) of mindfulness based on Kabat-Zinn program during one month

Timeline

Start date
2018-09-11
Primary completion
2021-05-03
Completion
2021-07-12
First posted
2017-10-24
Last updated
2023-12-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03318640. Inclusion in this directory is not an endorsement.